Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Type C Meeting Timings

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Apr 11, 2024 10:48am

82 Views

Post# 35983268

RE:RE:RE:RE:Type C Meeting Timings

Haha of course it says potential idiot, they haven't had the meeting yet.

ONCY know exactly what's going on with Bracelet, you think they'd schedule a meeting, in person or otherwise, If this was a stab in the dark?

Haha look at you clutching at straws. This is for Breast as well, the indication you said there was 100% likelihood never to happen!!!! What do you think the Panc news is going to be????

Should we all sell and lump in to Crispy? Hahaha

You seen margin call? The people who have shares here are both first and smart!!

John Tuld: There are three ways to make a living in this business: be first, be smarter, or cheat.

<< Previous

Bullboard Posts

Next >>

Mining companies take action on reconciliation with First Nations